The clinical-economic characteristic of current basis-bolus insulin therapy schemes in diabetes mellitus type 1 in adults

• Κύριοι συγγραφείς: A. S. Kolbin (Συγγραφέας), A. A. Kurilev (Συγγραφέας), Y. E. Balikina (Συγγραφέας), M. A. Proskurin (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Izdatelstvo OKI, 2022-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Basis-bolus insulin therapy is a cornerstone of Diabetes Mellitus type 1 (DM1T) control. Basal insulin analogs - glargine 300 U/ml (iGla 300), glargine 100 U/ml (iGla 100), detemir (iDet) degludec (iDeg), - as well as prandial insulins - glulisine (iGlu), aspart (iAsp) and lispro - are used widely d...